| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | 1 | 94 | 19 | 1 | 15 | 10 | 25 | 4 | - | 190 |
| - | - | 16 | - | - | - | 2 | 7 | 1 | - | 26 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | 2 | 21 | 7 | 1 | - | - | 31 |
| - | - | 13 | 17 | - | - | - | 30 |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(L) | 190 | 84.8% | -2.87 | 26 | 46.4% |
| LO(L) | 31 | 13.8% | -0.05 | 30 | 53.6% |
| Optic-unspecified(L) | 3 | 1.3% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns Tm3_unclear | % In | CV |
|---|---|---|---|---|---|
| Mi9 (L) | 9 | Glu | 21 | 10.2% | 0.5 |
| Mi1 (L) | 6 | ACh | 17 | 8.3% | 0.4 |
| Tm3 (L) | 5 | ACh | 16 | 7.8% | 0.4 |
| Mi4 (L) | 7 | GABA | 15 | 7.3% | 0.8 |
| TmY18 (L) | 5 | ACh | 14 | 6.8% | 0.5 |
| Li25 (L) | 4 | GABA | 11 | 5.3% | 0.5 |
| Tm37 (L) | 4 | Glu | 10 | 4.9% | 0.4 |
| Pm4 (L) | 2 | GABA | 7 | 3.4% | 0.4 |
| L3 (L) | 4 | ACh | 6 | 2.9% | 0.3 |
| Dm10 (L) | 3 | GABA | 5 | 2.4% | 0.6 |
| Cm3 (L) | 1 | GABA | 4 | 1.9% | 0.0 |
| TmY16 (L) | 2 | Glu | 4 | 1.9% | 0.5 |
| Pm1 (L) | 3 | GABA | 4 | 1.9% | 0.4 |
| Dm18 (L) | 3 | GABA | 4 | 1.9% | 0.4 |
| Mi2 (L) | 2 | Glu | 4 | 1.9% | 0.0 |
| ME_unclear (L) | 1 | Glu | 3 | 1.5% | 0.0 |
| Tm5c (L) | 1 | Glu | 3 | 1.5% | 0.0 |
| Pm9 (L) | 1 | GABA | 3 | 1.5% | 0.0 |
| MeVC11 (R) | 1 | ACh | 3 | 1.5% | 0.0 |
| Mi10 (L) | 2 | ACh | 3 | 1.5% | 0.3 |
| Tm16 (L) | 2 | ACh | 3 | 1.5% | 0.3 |
| Dm20 (L) | 2 | Glu | 3 | 1.5% | 0.3 |
| TmY15 (L) | 2 | GABA | 3 | 1.5% | 0.3 |
| L5 (L) | 3 | ACh | 3 | 1.5% | 0.0 |
| Mi18 (L) | 3 | GABA | 3 | 1.5% | 0.0 |
| MeVP6 (L) | 1 | Glu | 2 | 1.0% | 0.0 |
| TmY5a (L) | 1 | Glu | 2 | 1.0% | 0.0 |
| Cm20 (L) | 1 | GABA | 2 | 1.0% | 0.0 |
| Pm10 (L) | 2 | GABA | 2 | 1.0% | 0.0 |
| Li26 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| Tm4 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| Cm7 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| LPLC2 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| Cm29 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| T2 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| TmY19a (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| LC11 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| Tm39 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| T3 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| Mi16 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| Mi14 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| Cm5 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| Dm1 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| Pm5 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| Lawf1 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| Y13 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| Pm2a (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| TmY3 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| Pm8 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| MeLo14 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| Li11a (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| Dm13 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| aMe17c (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| LoVC16 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| MeVC25 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| downstream partner | # | NT | conns Tm3_unclear | % Out | CV |
|---|---|---|---|---|---|
| LC11 (L) | 4 | ACh | 16 | 13.6% | 0.5 |
| Mi4 (L) | 3 | GABA | 8 | 6.8% | 0.6 |
| Pm9 (L) | 1 | GABA | 6 | 5.1% | 0.0 |
| LT61a (L) | 1 | ACh | 6 | 5.1% | 0.0 |
| TmY18 (L) | 3 | ACh | 6 | 5.1% | 0.4 |
| TmY5a (L) | 4 | Glu | 5 | 4.2% | 0.3 |
| Pm3 (L) | 1 | GABA | 4 | 3.4% | 0.0 |
| Tm24 (L) | 1 | ACh | 4 | 3.4% | 0.0 |
| Li25 (L) | 2 | GABA | 4 | 3.4% | 0.5 |
| TmY15 (L) | 2 | GABA | 4 | 3.4% | 0.5 |
| LC21 (L) | 2 | ACh | 4 | 3.4% | 0.5 |
| Tm39 (L) | 3 | ACh | 4 | 3.4% | 0.4 |
| Mi10 (L) | 3 | ACh | 4 | 3.4% | 0.4 |
| MeLo12 (L) | 2 | Glu | 4 | 3.4% | 0.0 |
| MeVP4 (L) | 2 | ACh | 4 | 3.4% | 0.0 |
| MeLo8 (L) | 3 | GABA | 4 | 3.4% | 0.4 |
| Tm38 (L) | 1 | ACh | 3 | 2.5% | 0.0 |
| LPLC1 (L) | 1 | ACh | 3 | 2.5% | 0.0 |
| LC31a (L) | 1 | ACh | 2 | 1.7% | 0.0 |
| LC4 (L) | 1 | ACh | 2 | 1.7% | 0.0 |
| LC28 (L) | 1 | ACh | 2 | 1.7% | 0.0 |
| Tm37 (L) | 2 | Glu | 2 | 1.7% | 0.0 |
| LPLC2 (L) | 2 | ACh | 2 | 1.7% | 0.0 |
| Mi9 (L) | 1 | Glu | 1 | 0.8% | 0.0 |
| MeLo3b (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| Tm5b (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| Mi18 (L) | 1 | GABA | 1 | 0.8% | 0.0 |
| Tm29 (L) | 1 | Glu | 1 | 0.8% | 0.0 |
| MeLo7 (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| Tm3 (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| TmY13 (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| LC12 (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| Li14 (L) | 1 | Glu | 1 | 0.8% | 0.0 |
| MeLo9 (L) | 1 | Glu | 1 | 0.8% | 0.0 |
| Tm5c (L) | 1 | Glu | 1 | 0.8% | 0.0 |
| MeLo3a (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| LT51 (L) | 1 | Glu | 1 | 0.8% | 0.0 |
| Li38 (R) | 1 | GABA | 1 | 0.8% | 0.0 |